Isomorphic Labs Completes $5B Series C Funding to Advance Drug Candidates into Clinical Trials

Written by

in

Isomorphic Labs has completed $5 billion in Series C funding to advance its drug candidates into clinical trials, further develop its AI drug design engine, and expand into the healthcare sector.

Source:TechCrunch · Read Original

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *